Clinical Trial Update: Darapladib China PK [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of Darapladib conducted in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• Darapladib (darapladib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Atherosclerosis | Phase 1 | Status: COMPLETED